胚盤胞染色体異数性検査 で トルコ — 費用付きの上位 3 件のクリニックを取得します

Genetic testing for aneuploidy (PGT-A) screens IVF embryos for the correct number of chromosomes before implantation. It identifies embryos with extra or missing chromosomal material, known as aneuploidy, to improve pregnancy success rates and reduce the risk of miscarriage or chromosomal disorders.

• Chromosomal count: Checks all 23 pairs to ensure a normal 46-chromosome count (euploidy).
• Trisomy detection: Screens for extra chromosomes causing Down, Edwards, or Patau syndromes.
• Sex chromosomes: Identifies XX or XY chromosomes for gender determination and sex-linked conditions.
• Monosomy screening: Detects missing chromosomes, such as Turner syndrome (Monosomy X) in females.
• Mosaicism identification: Detects embryos containing a mix of both normal and abnormal cells.

Bookimed Expert Insight: While many clinics offer older FISH or Array-CGH methods, Turkey’s high-volume centers like Memorial Şişli Hospital prioritize Next-Generation Sequencing (NGS). NGS provides significantly higher resolution for detecting mosaicism. This technical edge is why patients from 167 countries choose Turkish labs for complex genetic screening.

Patient Consensus: Accuracy often depends on whether the biopsy occurs on day 5 or day 7. While a normal result is encouraging, it does not fully eliminate miscarriage risks related to uterine or non-chromosomal factors.

Embryologists perform biopsies at the blastocyst stage by using high-precision lasers to extract 5 to 10 cells from the trophectoderm. This outer layer eventually forms the placenta, leaving the inner cell mass that develops into the baby entirely untouched for maximum safety.

• Biopsy timing: Performed on day 5 or 6 when embryos have 100 to 200 cells.
• Laser technology: Precision lasers create a microscopic opening in the outer shell for safe extraction.
• Cell selection: Sampling only placental precursor cells maintains the integrity of the future fetus.
• Developmental impact: Research shows no increased risk of birth defects compared to standard IVF.
• Survival rate: Modern vitrification ensures the risk of embryo loss remains under 1 percent.

Bookimed Expert Insight: Turkish clinics like Memorial Şişli Hospital use Next Generation Sequencing (NGS) alongside a freeze-all strategy. This combination is a `coordinator’s secret` because it allows the embryo to recover from the biopsy. Transferring in a subsequent cycle often yields better success than fresh transfers.

Patient Consensus: Patients report high confidence in the process when labs confirm trophectoderm-only sampling. Most move forward knowing that identifying healthy embryos significantly reduces the emotional toll of unsuccessful transfers.

Genetic specialists use advanced techniques like Next-Generation Sequencing (NGS), Array-CGH, and FISH to analyze chromosomes for numerical or structural abnormalities. While rapid screenings take 2–5 days, comprehensive embryo testing in JCI-accredited Turkish facilities typically requires 7–14 days for detailed molecular reporting.

• Next-Generation Sequencing: High-resolution method detecting mosaicism and segmental aneuploidies with superior accuracy.
• Array-CGH technique: Balanced alternative for standard trisomies, often providing results within 10 days.
• FISH analysis: Rapid targeted screening for specific conditions, typically completed in 2–5 days.
• Results timeline: Most patients receive actionable sequence data within 7–21 days post-biopsy.

Bookimed Expert Insight: Data from major hubs like Memorial Şişli Hospital shows labs now prioritize NGS over older FISH methods. While NGS takes longer, it successfully identifies mosaic embryos that other tests might miss. To avoid delays, confirm if your clinic uses an on-site lab or ships samples to Europe.

Patient Consensus: Patients emphasize that while the technical lab work is fast, the true wait is the specialist consultation. Many recommend budgeting 3 weeks total to fully interpret complex mosaic results before proceeding with implantation.

Genetic counseling in Turkey is generally included as a standard part of IVF packages involving embryo aneuploidy testing. It provides a detailed clinical bridge between complex genetic data and your implantation decisions, covering chromosomal health, success probabilities, and emotional support throughout the multi-stage testing process.

• Risk assessment: Counselors analyze family history to identify patterns of inherited chromosomal conditions.
• Test education: Specialists explain what aneuploidy screening can and cannot detect for embryos.
• Results interpretation: Experts clarify the meaning of normal, mosaic, or abnormal biopsy results.
• Decision support: Clinicians provide non-directive guidance to help you choose the best embryos.

Bookimed Expert Insight: Top-tier Turkish centers like Memorial Şişli Hospital, the first in Turkey to earn JCI accreditation, often provide superior genetic data. While smaller clinics may offer only basic reports, large multidisciplinary hospitals utilize in-house genetics departments. This integration usually results in faster turnaround times and more comprehensive post-biopsy consultations included in the base price.

Patient Consensus: Patients find that while basic results are often shared via WhatsApp for convenience, detailed counseling for complex cases may require a specific request. Most appreciate the visual embryo grading reports provided alongside the genetic data.

Primary candidates for PGT-A include women over 35, patients with two or more miscarriages, or those with repeated IVF failures. This screening identifies embryos with 46 chromosomes to improve implantation success and reduce the time to a healthy pregnancy in Turkish JCI-accredited clinics.

• Advanced maternal age: Recommended for women 35+ to screen for age-related chromosomal abnormalities like aneuploidy.
• Recurrent pregnancy loss: Helps patients with 2 or more losses rule out genetic causes before transfer.
• Previous IVF failure: Essential if multiple high-quality embryo transfers failed to result in successful implantation.
• Single embryo transfer: Ideal for patients prioritizing a singleton pregnancy while maximizing successful implantation rates.

Bookimed Expert Insight: Data from top Turkish centers like Memorial Şişli Hospital shows that while PGT-A is highly effective for patients over 38, it can reduce your available embryo pool by 50%. For patients under 35 with high-quality blastocysts, the benefit is often marginal compared to the $3,000 cost. Always verify if your clinic holds ESHRE accreditation to ensure the biopsy is performed by specialized embryologists.

Patient Consensus: Patients over 40 often report that testing was the turning point after multiple losses, providing much-needed peace of mind. Conversely, younger responders often advise caution, noting that over-testing can lead to discarding potentially viable mosaic embryos unnecessarily.

Standard genetic testing packages in Turkey typically cover 5 to 8 embryos for a fixed cost. If you produce more, you can pay an additional fee per embryo, freeze extras without testing, or set a testing limit to stay within your initial budget.

• Testing capacity: Most Turkish clinic packages include screening for up to 8 embryos by default.
• Additional costs: Extra embryos usually cost between $300 and $600 each for genetic analysis.
• Alternative options: You may freeze overflow embryos untested to save costs or for future use.
• Provider variations: JCI-accredited centers like Memorial Şişli Hospital have specific protocols for handling extra embryos.

Bookimed Expert Insight: Turkish fertility centers often ask for your decision on `overflow` embryos immediately after retrieval while you are still recovering. Decide your maximum testing budget beforehand. Large networks like Memorial Healthcare Group offer specialized genetics departments that can manage high-volume cases more efficiently than smaller boutique clinics.

Patient Consensus: Expect the unexpected, as many patients retrieve 10 to 15 plus eggs and must quickly decide whether to pay for extra testing or face the psychological burden of leaving embryos untested in storage.

Recovery after egg retrieval in Turkey typically allows for a return to normal activities within 24 to 48 hours. Patients can generally travel on short flights after 2 days, though experts recommend waiting 7 days before long-distance travel to mitigate risks of blood clots or complications.

• Initial recovery: Expect 30–60 minutes in recovery for anesthesia to wear off before discharge.
• Physical symptoms: Mild cramping, bloating, and spotting usually resolve within 3 to 7 days.
• Flight safety: Wait at least 48 hours before flying to monitor for rare OHSS symptoms.
• Genetic testing: Results for aneuploidy screening typically take 7–14 days for up to 8 embryos.

Bookimed Expert Insight: Data from major Istanbul centers like Memorial Şişli Hospital suggests a strategic two-trip approach. Patients often fly home 3 days post-retrieval while awaiting genetic results. This avoids high hotel costs during the 14-day lab wait and ensures ovaries recover before the transfer trip.

Patient Consensus: Most patients feel surprisingly well by day 2 but advise wearing compression socks for the flight home. They emphasize staying locally for at least 48 hours to manage potential grogginess and bloating comfortably.

Preimplantation Genetic Testing for Aneuploidy (PGT-A) in Turkey screens up to 8 embryos to find those with the normal number of chromosomes. It helps select embryos with the best chance to implant and reduces miscarriage risk by avoiding embryos with chromosomal abnormalities.

• Embryo selection: Identifies euploid embryos for higher IVF success rates.
• Chromosomal screening: Detects trisomies and monosomies before transfer.
• Blastocyst biopsy: Cells from the outer embryo layer are tested at day 5–6.
• Results timeline: Takes 7 to 10 business days, up to 2–3 weeks with retesting.
• Not for genetic diseases: PGT-A does not diagnose inherited conditions.

Bookimed Expert Insight: Most leading Turkish IVF clinics use PGT-A to screen 8 embryos per cycle, balancing lab cost and results quality. Clinics like Memorial Şişli Hospital offer reliable testing within 10 days, but retesting borderline embryos can extend wait and cost. Australian patients benefit from lower overall IVF and genetic screening fees in Turkey compared to the US or UK.

Patient Consensus: Patients in Turkey say PGT-A helps choose embryos with better implantation chances and lowers miscarriage worries. Many highlight clear info on result timing and appreciate how clinics help decide on transfer versus freezing based on chromosome results.

PGT-A for up to 8 embryos in Turkey improves IVF outcomes by selecting chromosomally normal embryos, reducing miscarriage risks and increasing implantation success. Clinics use advanced genetic screening methods like Next-Generation Sequencing (NGS) for accurate results and support IVF cycle management from start to finish.

• Embryo selection: Identifies euploid embryos with correct chromosome numbers.
• Miscarriage reduction: Screens out embryos with major chromosomal abnormalities.
• Single embryo transfer: Allows safer pregnancy by selecting the healthiest embryo.
• Testing scope: Covers up to 8 embryos per cycle for greater success chances.
• Advanced technology: Leading Istanbul clinics like Memorial Şişli Hospital use NGS.

Bookimed Expert Insight: Turkey's IVF centres, such as Prof. Dr. Nilgün Turhan Clinic and Memorial Şişli Hospital, offer PGT-A testing alongside IVF with expert specialists experienced in genetic testing and embryo selection. Patients benefit from affordable prices and access to advanced genetics labs, with clinics accredited by Joint Commission International confirming strong safety and quality standards.

Patient Consensus: Australians value Turkey's affordable PGT-A testing for screening multiple embryos without breaking the bank. Many stress the importance of realistic expectations, knowing screening doesn’t guarantee pregnancy. Patients appreciate English-speaking coordinators and smooth follow-up care during the IVF process.

PGT-A in Turkey for up to 8 embryos is part of an IVF cycle with embryo biopsy and freezing. Genetic testing using Next-Generation Sequencing (NGS) checks all 24 chromosomes, improving embryo selection. Results take 7–14 days. This is followed by frozen embryo transfer.

• Embryo biopsy: Removes 3–10 cells from blastocysts on day 5 or 6.
• Freeze-all approach: Embryos freeze during genetic testing to protect viability.
• Genetic analysis: NGS screens embryos for aneuploidy in labs in Turkey.
• Legal use: PGT-A allowed only for medical reasons, like genetic abnormalities.
• Local anaesthesia: Used during embryo biopsy; outpatient procedure without hospital stay.

Bookimed Expert Insight: Top Turkish IVF clinics like Memorial Şişli Hospital offer PGT-A with JCI accreditation and advanced labs. Clinics commonly package PGT-A separately from IVF and schedule frozen embryo transfer after results. English-speaking staff and patient services in Istanbul make return visits easier for Australians.

Patient Consensus: Patients note PGT-A requires a return visit for embryo transfer after biopsy and freezing. Genetic test results usually take 1–2 weeks, sometimes longer. Ensuring the IVF package covers PGT-A for 8 embryos plus at least two frozen transfers helps prevent extra costs in Turkey.

Turkey strictly prohibits sex selection during PGT-A for non-medical reasons. Genetic tests may report sex chromosomes only if explicitly requested. Sex selection is legally allowed solely to prevent serious sex-linked diseases. Procedures must follow medical necessity rules.

• Legal restriction: Sex selection banned except to avoid genetic diseases.
• PGT-A use: Clinics provide sex chromosome info only on patient request.
• Eligibility: PGT-A and sex selection mainly available to married couples.
• Alternative options: Northern Cyprus permits sex selection with fewer restrictions.
• Clinic rules: Sex selection for family balancing or elective reasons is illegal.

Bookimed Expert Insight: Clinics like Memorial Şişli Hospital offer PGT-A with clear reporting but comply strictly with Turkey’s legal limits on sex selection. Most providers require documentation proving medical need before discussing embryo sex selection. Patients wanting elective gender choice often look to nearby Northern Cyprus for more flexible options.

Patient Consensus: Patients in Turkey say clinics share embryo sex info only if requested and for medical reasons. Many note the legal limits mean actual selection for non-medical purposes is not available, prompting some to consider Northern Cyprus instead.

Australians should consider that PGT-A in Turkey is not 100% accurate due to embryo mosaicism. The biopsy process may affect embryo survival, and differences in Turkish regulations can affect testing and embryo handling. Communication and follow-up care challenges may arise from distance.

• Accuracy limits: mosaic embryos risk false positives or negatives.
• Biopsy impact: removing 4–7 cells may reduce embryo implantation success.
• Regulatory differences: Turkish clinics follow distinct genetic testing rules.
• Follow-up care: remote reporting can complicate result explanations.
• Multiple IVF cycles: often needed due to high aneuploidy rates in embryos.

Bookimed Expert Insight: Clinics like Memorial Şişli Hospital with Joint Commission International (JCI) accreditation apply strict quality standards in genetic testing. However, Australian patients often face logistical complexities, including multi-cycle IVF and long-distance consultations, making clear upfront planning essential for smooth treatment abroad.

Patient Consensus: Many Australians note PGT-A’s limits in catching all abnormalities and the stress of waiting for biopsy results from Turkey. They advise budgeting for possible extra cycles and highlight the value of clinics that provide clear remote support during follow-up.

Turkey is popular among Australians for PGT-A testing on up to 8 embryos due to expert-led IVF with genetic screening, Joint Commission International (JCI) accredited clinics, and no age restrictions. Testing multiple embryos increases pregnancy success and reduces miscarriage risks.

• JCI accreditation: Memorial Şişli Hospital delivers high-quality genetic testing and IVF.
• No age limits: Turkey allows PGT-A regardless of age or miscarriage history.
• Testing capacity: Clinics test up to 8 embryos simultaneously for better embryo selection.
• Doctor-led care: Specialists like Dr Ali İhsan Gönenç plan individual IVF cycles and offer ongoing support.
• Cost advantage: PGT-A and IVF combined cost significantly less than in Australia.

Bookimed Expert Insight: Turkey’s top fertility centres combine JCI accreditation with advanced IVF labs, explaining high demand. Clinics like Memorial treat thousands annually with PGT-A, providing experience and better outcomes. Specialists prioritise personalised planning and clear communication, easing international patient journeys.

Patient Consensus: Australians appreciate Turkey’s open access to PGT-A without age limits. Many report better embryo selection and treatment success after previous failed attempts. Clear guidance on travel and medication helps Australians manage their cycles smoothly.

The process for international patients undergoing PGT-A for up to 8 embryos in Turkey involves two trips: ovarian stimulation, egg retrieval, and embryo biopsy with freezing, followed by genetic testing done remotely. Then a short second visit for frozen embryo transfer.

• Initial consultation: remote review of medical history and tests before travel.
• Egg retrieval: 5–7 days of ovarian stimulation and biopsy under local or general anaesthesia.
• PGT-A analysis: embryos frozen and tested remotely over 2–3 weeks.
• Frozen embryo transfer: 1–2 day visit to Istanbul after results to transfer healthy embryos.
• Local monitoring: blood tests and ultrasounds arranged at home or nearby clinics before transfer.

Bookimed Expert Insight: Clinics like Memorial Şişli Hospital provide JCI and ISO-accredited IVF and genetics services attracting patients from 167 countries. Coordinators arrange local monitoring to reduce travel stress. Two-trip scheduling is common; planning accommodation and transfers on both visits improves comfort for Australians.

Patient Consensus: Patients appreciate coordinators organising local blood tests to ease travel. The two visits split the tough procedures from the quick transfer. Clinics in Turkey have clean facilities and good interpreter access, which helps Aussie patients settle in easily.